TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

Telomerase reverse transcriptase (TERT) activity is up-regulated in several types of tumors including glioblastoma (GBM). In the present study, 128 primary glioblastoma patients were examined for single nucleotide polymorphisms of TERT in blood and in 92 cases for TERT promoter mutations in tumors....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Mosrati, Mohamed Ali, Malmström, Annika, Lysiak, Malgorzata, Krysztofiak, Adam, Hallbeck, Martin, Milos, Peter, Hallbeck, Anna-Lotta, Bratthäll, Charlotte, Strandéus, Michael, Stenmark-Askmalm, Marie, Söderkvist, Peter
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Clinical Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599297/
https://ncbi.nlm.nih.gov/pubmed/26143636
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items